The essence of the overall OADC mission -- facilitation and advancement of research in Alzheimer disease (AD) and dementia -- will be achieved by the establishment of a new core, the """"""""Genetics Core,"""""""" organized to support current research strengths as well as respond to the developing potential of new discoveries in the field. The major themes of the research supported by the Genetics Core are: AD pathogenesis; healthy aging of the brain; Parkinson dementia; and gender and ethnic differences in AD and healthy aging. Within this context, the Genetics Core's specific aims are: (1) to provide continuously updated genetic information (i.e., documented family history, genotype, and banking of DNA and plasma) for the five key cohorts enrolled in the OADC, including AD patients, healthy elderly, Native-American elderly, African-American AD subjects, and Parkinson patients; (2) to bridge basic science and clinical research by providing basic scientists with a detailed genetic characterization of the OADC post-mortem tissue, DNA samples from OADC subjects, and facilities and expertise to test for genetic linkage and association between AD and their molecules of interest (CNTF, CNTF receptor, acidic and basic FGF, FGF receptors 1-4, K+ channels, and others in the future); (3) to support ongoing collaborative genetic studies with the Seattle and the UCLA ADC's including genetic linkage studies of familial AD kindreds, examining the effects of HLA, ApoE, and gender on the age at onset of AD; (4) to collaborate with the OHSU Clinical Genetics Program and the OHSU DNA Diagnostic Laboratory to provide genetic counseling and risk assessment to the public; and (5) to participate in educational programs of the Education and Information Transfer Core and of the Alzheimer Association. The collaborations outlined above are funded independently. The contributions of the OADC Genetics Core to the collaborative research projects will be documented family histories, genotypes, and DNA and plasma from OADC subjects. Similarly, the public service programs for genetic counseling and testing will be financially independent of the OADC but will have close scientific ties with OADC investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG008017-09
Application #
6267411
Study Section
Project Start
1998-04-01
Project End
1999-03-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Blue, Elizabeth E; Bis, Joshua C; Dorschner, Michael O et al. (2018) Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project. Dement Geriatr Cogn Disord 45:1-17
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Lusardi, Theresa A; Wiedrick, Jack T; Malone, Molly et al. (2018) Analytics of Cerebrospinal Fluid MicroRNA Quantitative PCR Studies. Mol Neurobiol :
Leach, Julia M; Mancini, Martina; Kaye, Jeffrey A et al. (2018) Day-to-Day Variability of Postural Sway and Its Association With Cognitive Function in Older Adults: A Pilot Study. Front Aging Neurosci 10:126
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Mogg, Adrian J; Eessalu, Thomas; Johnson, Megan et al. (2018) In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography. J Pharmacol Exp Ther 365:602-613
Tulloch, Jessica; Leong, Lesley; Chen, Sunny et al. (2018) APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement 14:889-894
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27

Showing the most recent 10 out of 482 publications